Dino Polska Valuation
Is DNP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DNP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DNP (PLN333.9) is trading below our estimate of fair value (PLN478.23)
Significantly Below Fair Value: DNP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DNP?
Other financial metrics that can be useful for relative valuation.
What is DNP's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | zł32.74b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.2x |
Enterprise Value/EBITDA | 15.3x |
PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does DNP's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 35.6x | ||
EUR Eurocash | 71.9x | 29.1% | zł1.3b |
SHP Shoprite Holdings | 23.7x | 11.7% | R155.4b |
AMRT Sumber Alfaria Trijaya | 38.9x | 19.0% | Rp138.3t |
MGNT Magnit | 7.9x | 27.1% | ₽435.4b |
DNP Dino Polska | 23.1x | 17.4% | zł32.7b |
Price-To-Earnings vs Peers: DNP is good value based on its Price-To-Earnings Ratio (23.1x) compared to the peer average (44.8x).
Price to Earnings Ratio vs Industry
How does DNP's PE Ratio compare vs other companies in the European Consumer Retailing Industry?
Price-To-Earnings vs Industry: DNP is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the European Consumer Retailing industry average (15.5x).
Price to Earnings Ratio vs Fair Ratio
What is DNP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 23.1x |
Fair PE Ratio | 47.1x |
Price-To-Earnings vs Fair Ratio: DNP is good value based on its Price-To-Earnings Ratio (23.1x) compared to the estimated Fair Price-To-Earnings Ratio (47.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | zł333.90 | zł396.81 +18.8% | 14.8% | zł527.00 | zł299.00 | n/a | 14 |
Oct ’25 | zł342.00 | zł399.31 +16.8% | 15.3% | zł527.00 | zł299.00 | n/a | 14 |
Sep ’25 | zł322.50 | zł409.09 +26.9% | 14.6% | zł527.00 | zł299.00 | n/a | 14 |
Aug ’25 | zł344.40 | zł430.97 +25.1% | 12.5% | zł527.00 | zł340.00 | n/a | 14 |
Jul ’25 | zł398.20 | zł441.43 +10.9% | 12.0% | zł527.00 | zł340.00 | n/a | 14 |
Jun ’25 | zł392.10 | zł435.46 +11.1% | 12.0% | zł527.00 | zł340.00 | n/a | 13 |
May ’25 | zł389.90 | zł436.54 +12.0% | 13.0% | zł548.00 | zł350.00 | n/a | 12 |
Apr ’25 | zł387.70 | zł442.80 +14.2% | 13.2% | zł548.00 | zł350.00 | n/a | 12 |
Mar ’25 | zł461.70 | zł458.47 -0.7% | 13.0% | zł548.00 | zł367.00 | n/a | 12 |
Feb ’25 | zł447.10 | zł448.30 +0.3% | 13.6% | zł548.00 | zł367.00 | n/a | 12 |
Jan ’25 | zł460.70 | zł450.55 -2.2% | 14.0% | zł554.00 | zł367.00 | n/a | 12 |
Dec ’24 | zł456.50 | zł440.88 -3.4% | 15.6% | zł554.00 | zł322.00 | n/a | 12 |
Nov ’24 | zł398.50 | zł424.63 +6.6% | 14.6% | zł528.00 | zł322.00 | n/a | 12 |
Oct ’24 | zł355.00 | zł427.28 +20.4% | 13.9% | zł528.00 | zł322.00 | zł342.00 | 13 |
Sep ’24 | zł377.70 | zł431.44 +14.2% | 14.5% | zł535.00 | zł322.00 | zł322.50 | 13 |
Aug ’24 | zł449.10 | zł443.74 -1.2% | 14.6% | zł535.00 | zł322.00 | zł344.40 | 13 |
Jul ’24 | zł474.80 | zł430.13 -9.4% | 14.4% | zł537.00 | zł322.00 | zł398.20 | 13 |
Jun ’24 | zł442.00 | zł424.21 -4.0% | 13.1% | zł537.00 | zł322.00 | zł392.10 | 13 |
May ’24 | zł423.40 | zł408.59 -3.5% | 10.7% | zł482.00 | zł322.00 | zł389.90 | 13 |
Apr ’24 | zł391.10 | zł392.23 +0.3% | 10.8% | zł453.00 | zł322.00 | zł387.70 | 13 |
Mar ’24 | zł373.40 | zł389.23 +4.2% | 9.7% | zł450.00 | zł322.00 | zł461.70 | 13 |
Feb ’24 | zł380.40 | zł378.54 -0.5% | 12.6% | zł450.00 | zł303.00 | zł447.10 | 13 |
Jan ’24 | zł375.30 | zł373.15 -0.6% | 11.5% | zł434.00 | zł303.00 | zł460.70 | 13 |
Dec ’23 | zł365.10 | zł373.15 +2.2% | 11.5% | zł434.00 | zł303.00 | zł456.50 | 13 |
Nov ’23 | zł312.20 | zł361.00 +15.6% | 11.8% | zł420.00 | zł303.00 | zł398.50 | 13 |
Oct ’23 | zł302.00 | zł364.98 +20.9% | 11.9% | zł420.00 | zł303.00 | zł355.00 | 12 |
Analyst Forecast: Target price is less than 20% higher than the current share price.